Table 1.
Annotated angucyclines in the metabolomic profile of strain RO-S4.
Exp. m/z | Ion type | Molecular formula | Th. m/z | #a | tR (min) | Annotationb | |
---|---|---|---|---|---|---|---|
1 | 487.1600 | [M+H]+ | C25H26O10 | 487.1599 | 1 | 8.59 | Fridamycin A or B (Figure 4) |
2c | 469.1492 | [M+H]+ | C25H24O9 | 469.1493 | 1 | 8.48 | [1–H2O] |
3c | 529.1708 | [M+H]+ | C27H29O11 | 529.1704 | 1 | 8.58 | Acetyl-fridamycin A or B |
4c | 557.2383 | [M+H]+ | C30H36O10 | 557.2381 | 1 | 11.69 | See Figure 4 |
5c | 669.2903 | [M+H]+ | C36H44O12 | 669.2906 | 1 | 13.08 | n.a. |
6 | a: 597.1973; b: 597.1969 |
[M+H]+ | C31H32O12 | 597.1967 | 2 | a: 11.01; b: 12.57 |
a: Fridamycin D (Figure 4) |
7c | a: 711.2650; b: 711.2656 |
[M+H]+ | C37H42O14 | 711.2647 | 2 | a: 11.87; b: 11.17 |
See Figure 4 |
8c | 545.1808 | [M+H]+ | C31H28O9 | 545.1806 | 1 | 14.21 | n.a. |
9c | 667.2751 | [M+H]+ | C36H42O12 | 667.2749 | 1 | 13.66 | See Figure 4 |
10c | 781.3436 | [M+H]+ | C42H52O14 | 781.3430 | 1 | 14.31 | See Figure 4 |
11c | a: 675.2438; b: 675.2436 | [M+H]+ | C37H38O12 | 675.2436 | 2 | a: 13.74; b: 13.10 | See Figure 4 |
12c | 677.2597 | [M+H]+ | C37H40O12 | 677.2593 | 1 | 11.02 | See Figure 4 |
13c | 763.3328 | [M+H]+ | C42H50O13 | 763.3324 | 1 | 12.88 | n.a. |
14c | 917.3601 | [M+H]+ | C49H56O17 | 917.3590 | 1 | 12.03 | See Figure 4 |
15c | a: 819.2863; b: 819.2869 | [M+H]+ | C43H46O16 | 819.2859 | 2 | a: 12.64; b: 12.95 | n.a. |
16c | 901.3647 | [M+H]+ | C49H56O16 | 901.3641 | 1 | 12.94 | See Figure 4 |
17 | 952.3957 | [M+NH4]+ | C49H58O18 | 952.3961 | 1 | 12.27 | Vineomycin B2 (Figure 4) |
18c | a: 599.2124; b: 599.2125 |
[M+H]+ | C31H34O12 | 599.2123 | 2 | a: 10.11; b: 10.53 |
See Figure 4 |
19c | a: 601.2284; b: 601.2288 |
[M+H]+ | C31H36O12 | 601.2279 | 2 | a: 10.06; b: 10.95 |
See Figure 4 |
20c | 583.2170 | [M+H]+ | C31H34O11 | 583.2174 | 1 | 8.62 | [19a–H2O] |
21c | 697.2861 | [M+H]+ | C37H44O13 | 697.2855 | 1 | 9.32 | See Figure 4 |
22c | 585.2333 | [M+H]+ | C31H36O11 | 585.2330 | 1 | 10.87 | n.a. |
23 | 713.2782 | [M+H]+ | C37H44O14 | 713.2804 | 1 | 11.88 | n.a. |
24c | 672.2655 | [M+H]+ | C34H41NO13 | 672.2652 | 1 | 9.70 | See Figure 4 |
25c | 743.3031 | [M+H]+ | C37H46N2O14 | 743.3022 | 1 | 9.44 | See Figure 4 |
26c | 813.3816 | [M+H]+ | C42H56N2O14 | 813.3804 | 1 | 11.55 | n.a. |
27c | 857.3709 | [M+H]+ | C43H56N2O16 | 857.3703 | 1 | 10.24 | See Figure 4 |
28c | 709.2490 | [M+H]+ | C37H40O14 | 709.2491 | 1 | 10.95 | n.a. |
29c | 595.1808 | [M+H]+ | C31H30O12 | 595.1810 | 1 | 9.47 | n.a. |
30c | 705.2182 | [M+H]+ | C37H36O14 | 705.2178 | 1 | 11.83 | n.a. |
Number of isomers detected in the MN cluster.
Proposed structures are annotations based on literature data and automatic and manual analysis of MS2 spectra.
n.a., not annotated.
Novel compound.